Literature DB >> 15718035

Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.

Marco Duering1, Marcus O W Grimm, Heike S Grimm, Johannes Schröder, Tobias Hartmann.   

Abstract

More than 130 known mutations in the presenilin-1 (PS1) gene result in familial Alzheimer's disease (FAD) with a mutation specific age of disease onset. These mutations increase amyloid beta 42 (A beta42) levels, and this increase has been validated in recent years as one pathogenic factor in FAD. However, further malfunctions of mutant presenilin-1 are discussed as well. In order to assess the weight of A beta42 regarding the pathogenesis of FAD, we expressed mutant forms of PS1 (30-65 years onset age) in COS-7 cells and analyzed amyloid beta levels by a novel ELISA. We found a strong correlation (r = 0.98; p<0.001) between the A beta40/42-ratio and mean age of disease onset indicating a substantial extent of A beta42 contribution to FAD pathology. Our data strongly suggest that A beta42 is the decisive factor for age of onset in FAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718035     DOI: 10.1016/j.neurobiolaging.2004.08.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  38 in total

1.  Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice.

Authors:  Götz Heilbronner; Yvonne S Eisele; Franziska Langer; Stephan A Kaeser; Renata Novotny; Amudha Nagarathinam; Andreas Aslund; Per Hammarström; K Peter R Nilsson; Mathias Jucker
Journal:  EMBO Rep       Date:  2013-09-03       Impact factor: 8.807

Review 2.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

Review 3.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

Review 4.  Cell signaling abnormalities may drive neurodegeneration in familial Alzheimer disease.

Authors:  Nikolaos K Robakis
Journal:  Neurochem Res       Date:  2013-02-23       Impact factor: 3.996

Review 5.  Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives.

Authors:  Nikolaos K Robakis
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

Review 6.  Filling the void: a role for exercise-induced BDNF and brain amyloid precursor protein processing.

Authors:  Rebecca E K MacPherson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-16       Impact factor: 3.619

7.  Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.

Authors:  Lan Ye; Jay Rasmussen; Stephan A Kaeser; Anne-Marie Marzesco; Ulrike Obermüller; Jasmin Mahler; Juliane Schelle; Jörg Odenthal; Christian Krüger; Sarah K Fritschi; Lary C Walker; Matthias Staufenbiel; Frank Baumann; Mathias Jucker
Journal:  EMBO Rep       Date:  2017-07-12       Impact factor: 8.807

8.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

9.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

Review 10.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.